Latest Regulatory Milestones News

Memphasys has sharpened its commercial focus on the Felix™ System, securing a major distribution expansion in the MENA region and cutting operational costs by 40%, setting the stage for a global market push.

Australian Vanadium Limited advances its vertically integrated vanadium strategy with key regulatory approvals, manufacturing expansions, and a new $10 million loan facility, positioning itself for major energy storage projects.

Bubs Australia reported a 30% increase in net revenue to $25.6 million for Q1 FY26, driven by robust US sales and a return to profitability with positive EBITDA. Despite inventory challenges in other regions, the company maintains a solid cash position and anticipates FDA approval by year-end.

Percheron Therapeutics reports encouraging phase I clinical results for HMBD-002, confirming safety and early efficacy signals, while gearing up for a multi-arm phase II trial in 2026.

Globe Metals & Mining advances its Kanyika Niobium Project with a regulatory extension, licence expansion to new critical minerals, and a significant capital raise, positioning the company for its next development phase.

Cobre Limited has reported a maiden Mineral Resource Estimate for its Ngami Copper Project in Botswana, alongside a significant investment agreement with Sinomine International Exploration. The company also advanced exploration activities with BHP funding and progressed key permitting milestones.

Far East Gold reports a productive September quarter with significant drilling results at its Idenburg Project, including a new high-grade discovery at North Bermol and an expanded pipeline of exploration targets.

Piche Resources has secured crucial environmental approvals for its Argentine projects, setting the stage for an extensive drilling campaign at Cerro Chacón and advancing uranium exploration at Sierra Cuadrada and Ashburton.

Legacy Iron Ore Limited reported solid progress in its September 2025 quarter, advancing gold production at South Laverton and pushing forward feasibility and environmental studies at the Mount Bevan magnetite project.

Cobalt Blue Holdings advances its Kwinana Cobalt Refinery with a critical Works Approval and secures letters of intent covering 70% of initial production, while its Broken Hill Cobalt Project gains a three-year Major Project Status extension.

Southern Palladium has cleared major regulatory hurdles and confirmed robust economics for its Bengwenyama platinum group metals project, supported by a $20 million capital raise to fund next-stage development.

Cleo Diagnostics has successfully completed Stage 1 of the Medical Device Single Audit Program, marking a significant step toward FDA submission and global commercialisation of its ovarian cancer test.